Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Treat Rev. 2004 Dec;30(8):715-7.

Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer.

[No authors listed]
PMID:
15541582
DOI:
10.1016/j.ctrv.2004.09.003
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center